UBQLN1 and hepatocellular carcinoma: In conclusion, this study revealed that UBQLN1-PGC1β-mediated mitochondrial biogenesis and ROS homeostasis play critical roles in sorafenib resistance in HCC, providing a potential signaling pathway and novel targets for combination therapies.